IL-PRICEFX
30.1.2020 13:02:12 CET | Business Wire | Press release
Pricefx , the global leader in cloud pricing software, today announced another year of tremendous growth during its fiscal year ending December, 31, 2019. The company has grown by 85% on average each year for the last four years – 3 to 4 times the industry standard for pricing companies. As a result, Pricefx is continuing to expand its market share, particularly in the U.S. where the company more than doubled its total revenue.
Market Demand and Customer Wins
Gartner Inc. included Pricefx in the Magic Quadrant for Configure, Price and Quote Application Suites , as well as the Hype Cycle for CRM Sales Technology, 2019 as a Sample Vendor of Price Optimization and Management for B2B. The latter report states, “price optimization and management is close to the Plateau of Productivity because it is able to demonstrate quantifiable and tangible improvements in margin and revenue in successful implementations.”
Additionally, Gartner’s Market Guide for B2B Price Optimization and Management Software for 2019 includes Pricefx and states that it expects “the PO&M market to continue to grow rapidly during the next three years” and that “PO&M software has a rapid payback on investment (often less than six months).”
Pricefx currently has more than 100 customers across 37 countries, which include some of the largest manufacturing, retailing and energy businesses in the world. In 2019, Pricefx signed nearly 20 new enterprise customers with revenue in excess of $2 billion. New customers include Lyreco, Phillips 66, Scotts-Miracle Gro and Watsco.
Company Expansion
To scale for the rising demand of its easy-to-use pricing solutions, Pricefx also expanded its footprint in North America. The company more than doubled its headcount, adding 140 new employees in 2019.
In November 2019, Pricefx closed its Series B financing round with a total of €48 million in its coffers, which will be used to fuel the company’s continued market expansion and product development. On the heels of this latest funding, the company’s valuation has nearly tripled in the last twelve months.
Product Accolades and Advancements
Last year, Pricefx became the first solution provider to achieve Gold-Level Status for SAP® PartnerEdge® Build. The company also secured the highest rating on G2 Crowd for enterprise-grade pricing software. Pricefx won Product of the Year in the 2019 Sales and Marketing Technology awards (SAMMYs), the only pricing solution to do so, and was named the Gold winner in Enterprise Product of the Year - Sales Software.
The 2019 SaaS Awards program named Pricefx a finalist in the category “Best SaaS Product for Sales / Marketing” and the company was named a Bronze winner for Cloud Computing/SaaS Product or Service for Sales by the Customer Sales & Service World Awards .
Pricefx also completed its evolution to an enterprise-grade platform , announcing that subscribers of the company’s core SaaS product offerings receive full access to the entire platform feature set for no additional cost. By including the platform with core product subscriptions, Pricefx further lowered the total cost of ownership for its customers.
The fall product release brought forth Unity UI , a sleek, modern, intuitive user interface. Unity represented the first major UI update for Pricefx since its initial launch and dramatically improved the ease of use, consistency and responsiveness of Pricefx to create a better user experience on multiple devices. Last spring, Pricefx announced plug-and-play integrations between its CPQ software and the industry’s leading enterprise-grade customer relationship management (CRM) solutions, including Salesforce, Microsoft Dynamics 365 and SAP Cloud for Customer.
“In 2019, Pricefx continued to deliver a fast, flexible and friendly pricing solution to enterprises looking to increase revenue and profits,” said Patrick Adams, chief revenue officer of Pricefx. “Investor support, industry accolades, customer wins and new product innovation point to strong demand for Pricefx’s true cloud-native pricing platform. We are excited about 2019’s results and expect to continue our amazing growth into 2020 with expanded adoption of the platform and new solutions designed to give our customers a competitive edge.”
In Q1 2020, Pricefx Advantage, the company’s new partner program, will officially launch. The program seeks to create a connected ecosystem of pricing strategists, system integrators and Independent Software Vendors (ISV’s) who will team with Pricefx to help customers achieve pricing superiority at scale, faster than anyone else in the market.
Follow Pricefx
Blog: https://www.pricefx.com/site/blog/
Twitter: https://twitter.com/price_fx
LinkedIn: https://www.linkedin.com/company/price-f-x-/
About Pricefx
Established in 2011 in Germany, Pricefx is the global leader in SaaS pricing software, offering a comprehensive suite of solutions that are fast to implement, flexible to configure and customize, and friendly to learn and use. Pricefx delivers a complete price optimization and management platform based on native cloud architecture, providing industry leading time to value and total cost of ownership advantages to customers. Their innovative solution works for both B2B and B2C enterprises of any size, in any industry, in any part of the world. Pricefx’s business model is entirely based on the satisfaction and loyalty of its customers. Today, Pricefx delivers Passion for Pricing to more than 100 customers in more than 37 countries worldwide. For more information, please visit www.pricefx.com .
Gartner Disclaimer: Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200130005160/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom